TG Therapeutics, Inc. (TGTX) Valuation — DCF & Advanced Analysis | MarketCI

TG

TGTX

Market Closed

TG Therapeutics, Inc.

US

352 employees

CEO: Michael S. Weiss

Founded: 2010

$46.62

+$0.00(+NaN%)

Market Cap

7.14B

Beta

1.68

52W Range

N/A

Dividend Yield

0.00%

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: No specific insights available at this time.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore TGTX

Key metrics and AI-powered insights

Price targets and earnings estimates

Income, balance sheet and cash flow

P/E, DCF and valuation multiples

Institutional and insider holdings

Analyst ratings and news sentiment

TGTX in the Healthcare

Mid Cap

Browse sector stocks →

Browse industry stocks →